These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 16864979)

  • 1. IgE-mediated allergen presentation and blocking antibodies: regulation of T-cell activation in allergy.
    van Neerven RJ; Knol EF; Ejrnaes A; Würtzen PA
    Int Arch Allergy Immunol; 2006; 141(2):119-29. PubMed ID: 16864979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind placebo-controlled birch allergy vaccination study II: correlation between inhibition of IgE binding, histamine release and facilitated allergen presentation.
    Würtzen PA; Lund G; Lund K; Arvidsson M; Rak S; Ipsen H
    Clin Exp Allergy; 2008 Aug; 38(8):1290-301. PubMed ID: 18510696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation.
    van Neerven RJ; Wikborg T; Lund G; Jacobsen B; Brinch-Nielsen A; Arnved J; Ipsen H
    J Immunol; 1999 Sep; 163(5):2944-52. PubMed ID: 10453043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facilitated antigen presentation and its inhibition by blocking IgG antibodies depends on IgE repertoire complexity.
    Holm J; Willumsen N; Würtzen PA; Christensen LH; Lund K
    J Allergy Clin Immunol; 2011 Apr; 127(4):1029-37. PubMed ID: 21377718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergen-Specific Antibodies Regulate Secondary Allergen-Specific Immune Responses.
    Eckl-Dorna J; Villazala-Merino S; Linhart B; Karaulov AV; Zhernov Y; Khaitov M; Niederberger-Leppin V; Valenta R
    Front Immunol; 2018; 9():3131. PubMed ID: 30705676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgE-facilitated antigen presentation: role in allergy and the influence of allergen immunotherapy.
    Wilcock LK; Francis JN; Durham SR
    Immunol Allergy Clin North Am; 2006 May; 26(2):333-47, viii-ix. PubMed ID: 16701148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody repertoire complexity and effector cell biology determined by assays for IgE-mediated basophil and T-cell activation.
    Lund G; Willumsen N; Holm J; Christensen LH; Würtzen PA; Lund K
    J Immunol Methods; 2012 Sep; 383(1-2):4-20. PubMed ID: 22683539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.
    Focke M; Swoboda I; Marth K; Valenta R
    Clin Exp Allergy; 2010 Mar; 40(3):385-97. PubMed ID: 20210812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive immunization with allergen-specific antibodies.
    Flicker S; Gadermaier E; Madritsch C; Valenta R
    Curr Top Microbiol Immunol; 2011; 352():141-59. PubMed ID: 21681684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renaissance of the blocking antibody concept in type I allergy.
    Flicker S; Valenta R
    Int Arch Allergy Immunol; 2003 Sep; 132(1):13-24. PubMed ID: 14555854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation and targeting of T-cell immune responses by IgE and IgG antibodies.
    Bheekha Escura R; Wasserbauer E; Hammerschmid F; Pearce A; Kidd P; Mudde GC
    Immunology; 1995 Nov; 86(3):343-50. PubMed ID: 8550069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin G in IgE-mediated allergy and allergen-specific immunotherapy.
    Hofmaier S; Comberiati P; Matricardi PM
    Eur Ann Allergy Clin Immunol; 2014 Jan; 46(1):6-11. PubMed ID: 24702866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum-IgE-facilitated allergen presentation in atopic disease.
    van der Heijden FL; Joost van Neerven RJ; van Katwijk M; Bos JD; Kapsenberg ML
    J Immunol; 1993 Apr; 150(8 Pt 1):3643-50. PubMed ID: 8468493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissection of the grass allergen-specific immune response in patients with allergies and control subjects: T-cell proliferation in patients does not correlate with specific serum IgE and skin reactivity.
    Würtzen PA; van Neerven RJ; Arnved J; Ipsen H; Sparholt SH
    J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):241-9. PubMed ID: 9500758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of IgE/CD23-mediated antigen presentation in allergy.
    Mudde GC; Bheekha R; Bruijnzeel-Koomen CA
    Immunol Today; 1995 Aug; 16(8):380-3. PubMed ID: 7546193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of IgG antibodies in allergy and immunotherapy.
    Aalberse R
    Allergy; 2011 Jul; 66 Suppl 95():28-30. PubMed ID: 21668848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergen-specific T lymphocytes as targets for specific immunotherapy: striking at the roots of type I allergy.
    Bohle B
    Arch Immunol Ther Exp (Warsz); 2002; 50(4):233-41. PubMed ID: 12371619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy.
    Wachholz PA; Soni NK; Till SJ; Durham SR
    J Allergy Clin Immunol; 2003 Nov; 112(5):915-22. PubMed ID: 14610480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination for birch pollen allergy: comparison of the affinities of specific immunoglobulins E, G1 and G4 measured by surface plasmon resonance.
    Jakobsen CG; Bodtger U; Poulsen LK; Roggen EL
    Clin Exp Allergy; 2005 Feb; 35(2):193-8. PubMed ID: 15725191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
    Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
    J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.